Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 4, p. 424, doi. 10.7150/ntno.76370
- By:
- Publication type:
- Article
Works matching IS 22067418 AND DT 2022 AND VI 6 AND IP 4
Results: 8
1
2
Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 4, p. 400, doi. 10.7150/ntno.74613
- By:
- Publication type:
- Article
3
Covalent core-radiolabeling of polymeric micelles with <sup>125</sup>I/<sup>211</sup>At for theranostic radiotherapy.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 4, p. 388, doi. 10.7150/ntno.71906
- By:
- Publication type:
- Article
4
Ultrasound-triggered oxygen-loaded nanodroplets enhance and monitor cerebral damage from sonodynamic therapy.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 4, p. 376, doi. 10.7150/ntno.71946
- By:
- Publication type:
- Article
5
Progress on Applying Carbon Dots for Inhibition of RNA Virus Infection.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 4, p. 436, doi. 10.7150/ntno.73918
- By:
- Publication type:
- Article
6
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 4, p. 451, doi. 10.7150/ntno.75045
- By:
- Publication type:
- Article
7
Emerging Role of Edible Exosomes-Like Nanoparticles (ELNs) as Hepatoprotective Agents.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 4, p. 365, doi. 10.7150/ntno.70999
- By:
- Publication type:
- Article
8
A 2D nanotheranostic platform based on graphene oxide and phase-change materials for bimodal CT/MR imaging, NIR-activated drug release, and synergistic thermo-chemotherapy.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 4, p. 350, doi. 10.7150/ntno.64790
- By:
- Publication type:
- Article